Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Food and Drug Administration PubMed PubMed No published multi year surveillance exists for adverse events, and current absence of large documented harm does not imply safety equivalence to approved therapeutics with rigorous post marketing data
Schoenenberger GA, Maier PF, Tobler HJ, Monnier M
As a 2025 narrative review in PubMed confirming BPC-157 promotes angiogenesis, accelerates tendon and bone healing, and protects gastrointestinal lining across multiple animal models notes, the current evidence base is robust in preclinical settings with no approved human trials completed to date
Contraindications and Cautions: Certain individuals should avoid GHK-Cu injections or use extra care
Why Oral BPC-157 Works When Most Oral Peptides Don't Most therapeutic peptides cannot be taken orally because stomach acid and digestive enzymes (pepsin, trypsin) break them down before they reach the gut mucosa
Shaking causes shearing forces that can denature the peptide, rendering it useless
